Image

Effect of Intra-session Exercise Modes Sequence on Ventricular Function in Patients with Chronic Heart Failure

Effect of Intra-session Exercise Modes Sequence on Ventricular Function in Patients with Chronic Heart Failure

Recruiting
55-65 years
Male
Phase N/A

Powered by AI

Overview

The aim of this study was to investigate the effect of intra-session exercise modes sequence on ventricular function in patients with chronic heart failure.

Description

Sixty male patients with chronic heart failure will be recruited in this study from National Heart Institute Giza, Egypt. Their ages will be ranged from 55 to 65 years old and they will be randomly divided into three groups as following:

  1. Study group (A) includes 20 patients who will receive intra-session exercise modes sequence of aerobic cardiovascular training (CVT) then resistance training (RT) exercises in addition to routine treatment programme.
  2. Study group (B) includes 20 patients who will receive intra-session exercise modes sequence of resistance training (RT) then aerobic cardiovascular training (CVT) exercises in addition to routine treatment programme.
  3. Control group (C) includes 20 patients who will receive routine treatment programme only.

The exercise training programme for both study groups A and B will be applied once per day, three times per week for 12 consecutive weeks.

Inclusion criteria:

All participated patients will be:

  • Male patients with chronic heart failure and ages from 55 to 65 years old.
  • Class II and class III heart failure according to NYHA classification.
  • HFrEF category with LVEF <40% as documented by echocardiogram within <6 months.
  • Receiving the same medical treatment programme for at least 3 months.
  • Having a close level of functional capacity assessed by 6 minute walking test.

Exclusion criteria:

Patients who meet one of the following criteria will be excluded:

  • Uncontrolled atrial fibrillation.
  • Diabetes mellitus.
  • Myocardial infarction or recurrent angina within <3 months.
  • Patients with chronic chest diseases.
  • Severe stenotic valvular disease.
  • Clinically significant peripheral vascular disease.
  • Exercise-induced angina, ST segment changes or exercise induce AV block.
  • Patients with chronic renal failure.
  • Any cognitive impairment that interferes with prescribed exercise procedures.
  • Musculoskeletal or neurological limitation to physical exercise.

RESEARCH ETHICS

The protocol of this study will be approved by the ethics committee of scientific research at the Faculty of Physical Therapy, Cairo University. The study procedure will be explained in details for every patient before the initial assessment. All patients will be informed about the purpose, nature, and potential risks of the study, and a written informed consent will be obtained before participation in the study. The participants' right confidentiality will be observed strictly.

Eligibility

Inclusion Criteria:

  • Male patients with chronic heart failure and ages from 55 to 65 years old.
    • Class II and class III heart failure according to NYHA classification.
    • HFrEF category with LVEF <40% as documented by echocardiogram within <6 months.
    • Receiving the same medical treatment programme for at least 3 months.
    • Having a close level of functional capacity assessed by 6 minute walking test

Exclusion Criteria:

  • • Uncontrolled atrial fibrillation.
    • Diabetes mellitus.
    • Myocardial infarction or recurrent angina within <3 months.
    • Patients with chronic chest diseases.
    • Severe stenotic valvular disease.
    • Clinically significant peripheral vascular disease.
    • Exercise-induced angina, ST segment changes or exercise induce AV block.
    • Patients with chronic renal failure.
    • Any cognitive impairment that interferes with prescribed exercise procedures.
    • Musculoskeletal or neurological limitation to physical exercise.

Study details
    Heart Failure

NCT06626542

Cairo University

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.